Download PDF
Semin Neurol 2019; 39(05): 570-577
DOI: 10.1055/s-0039-1688977
Review Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Small Fiber Neuropathy

Lan Zhou
1   Departments of Neurology and Pathology, BMC Cutaneous Nerve Laboratory, Boston University Medical Center, Boston, Massachusetts
› Author Affiliations
Further Information

Publication History

Publication Date:
22 October 2019 (online)

    Permissions and Reprints

Abstract

Small fiber neuropathy (SFN) is common, and can be associated with many medical conditions. The majority of the patients with SFN suffer from painful paresthesia which can negatively impact their quality of life. Skin biopsy with intraepidermal nerve fiber density evaluation is the gold standard diagnostic test. Autonomic function testing is useful when autonomic symptoms are present. Screening for associated conditions should be done in every patient, even when a known underlying associated condition is present, before the neuropathy evaluation. Etiology-specific treatment, lifestyle modification, and pain control are the key elements of SFN management. This article will review the clinical presentation, skin biopsy procedure, utility of diagnostic tests, associated conditions, management, and prognosis of SFN.

Keywords

small fiber neuropathy - skin biopsy - management
 

  • References

  • 1 Tavee J, Zhou L. Small fiber neuropathy: a burning problem. Cleve Clin J Med 2009; 76 (05) 297-305
    CrossrefPubMedGoogle Scholar
  • 2 de Greef BTA, Hoeijmakers JGJ, Gorissen-Brouwers CML, Geerts M, Faber CG, Merkies ISJ. Associated conditions in small fiber neuropathy - a large cohort study and review of the literature. Eur J Neurol 2018; 25 (02) 348-355
    CrossrefPubMedGoogle Scholar
  • 3 Khan S, Zhou L. Characterization of non-length-dependent small-fiber sensory neuropathy. Muscle Nerve 2012; 45 (01) 86-91
    CrossrefPubMedGoogle Scholar
  • 4 Cazzato D, Lauria G. Small fibre neuropathy. Curr Opin Neurol 2017; 30 (05) 490-499
    CrossrefPubMedGoogle Scholar
  • 5 Chan AC, Wilder-Smith EP. Small fiber neuropathy: Getting bigger!. Muscle Nerve 2016; 53 (05) 671-682
    CrossrefPubMedGoogle Scholar
  • 6 Peters MJ, Bakkers M, Merkies IS, Hoeijmakers JG, van Raak EP, Faber CG. Incidence and prevalence of small-fiber neuropathy: a survey in the Netherlands. Neurology 2013; 81 (15) 1356-1360
    CrossrefPubMedGoogle Scholar
  • 7 Bakkers M, Faber CG, Hoeijmakers JG, Lauria G, Merkies IS. Small fibers, large impact: quality of life in small-fiber neuropathy. Muscle Nerve 2014; 49 (03) 329-336
    CrossrefPubMedGoogle Scholar
  • 8 Gordois A, Scuffham P, Shearer A, Oglesby A, Tobian JA. The health care costs of diabetic peripheral neuropathy in the US. Diabetes Care 2003; 26 (06) 1790-1795
    CrossrefPubMedGoogle Scholar
  • 9 Lacomis D. Small-fiber neuropathy. Muscle Nerve 2002; 26 (02) 173-188
    CrossrefPubMedGoogle Scholar
  • 10 Gemignani F, Giovanelli M, Vitetta F. , et al. Non-length dependent small fiber neuropathy. a prospective case series. J Peripher Nerv Syst 2010; 15 (01) 57-62
    CrossrefPubMedGoogle Scholar
  • 11 Misery L, Brenaut E, Le Garrec R. , et al. Neuropathic pruritus. Nat Rev Neurol 2014; 10 (07) 408-416
    CrossrefPubMedGoogle Scholar
  • 12 Lauria G, Hsieh ST, Johansson O. , et al. European Federation of Neurological Societies/Peripheral Nerve Society Guideline on the use of skin biopsy in the diagnosis of small fiber neuropathy. Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society. Eur J Neurol 2010; 17: 903-912 , e944–909
    CrossrefPubMedGoogle Scholar
  • 13 Gibbons CH. Small fiber neuropathies. Continuum (Minneap Minn) 2014; 20 (5 Peripheral Nervous System Disorders): 1398-1412
    PubMedGoogle Scholar
  • 14 Tavee JO, Karwa K, Ahmed Z, Thompson N, Parambil J, Culver DA. Sarcoidosis-associated small fiber neuropathy in a large cohort: clinical aspects and response to IVIG and anti-TNF alpha treatment. Respir Med 2017; 126: 135-138
    CrossrefPubMedGoogle Scholar
  • 15 Thaisetthawatkul P, Fernandes Filho JA, Herrmann DN. Contribution of QSART to the diagnosis of small fiber neuropathy. Muscle Nerve 2013; 48 (06) 883-888
    CrossrefPubMedGoogle Scholar
  • 16 Chai J, Herrmann DN, Stanton M, Barbano RL, Logigian EL. Painful small-fiber neuropathy in Sjogren syndrome. Neurology 2005; 65 (06) 925-927
    CrossrefPubMedGoogle Scholar
  • 17 Gorson KC, Herrmann DN, Thiagarajan R. , et al. Non-length dependent small fibre neuropathy/ganglionopathy. J Neurol Neurosurg Psychiatry 2008; 79 (02) 163-169
    CrossrefPubMedGoogle Scholar
  • 18 Tesfaye S, Boulton AJ, Dyck PJ. , et al; Toronto Diabetic Neuropathy Expert Group. Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments. Diabetes Care 2010; 33 (10) 2285-2293
    CrossrefPubMedGoogle Scholar
  • 19 Terkelsen AJ, Karlsson P, Lauria G, Freeman R, Finnerup NB, Jensen TS. The diagnostic challenge of small fibre neuropathy: clinical presentations, evaluations, and causes. Lancet Neurol 2017; 16 (11) 934-944
    CrossrefPubMedGoogle Scholar
  • 20 Kennedy WR, Wendelschafer-Crabb G. The innervation of human epidermis. J Neurol Sci 1993; 115 (02) 184-190
    CrossrefPubMedGoogle Scholar
  • 21 McCarthy BG, Hsieh ST, Stocks A. , et al. Cutaneous innervation in sensory neuropathies: evaluation by skin biopsy. Neurology 1995; 45 (10) 1848-1855
    CrossrefPubMedGoogle Scholar
  • 22 Wang L, Hilliges M, Jernberg T, Wiegleb-Edström D, Johansson O. Protein gene product 9.5-immunoreactive nerve fibres and cells in human skin. Cell Tissue Res 1990; 261 (01) 25-33
    CrossrefPubMedGoogle Scholar
  • 23 Devigili G, Tugnoli V, Penza P. , et al. The diagnostic criteria for small fibre neuropathy: from symptoms to neuropathology. Brain 2008; 131 (Pt 7): 1912-1925
    CrossrefPubMedGoogle Scholar
  • 24 Lauria G, Holland N, Hauer P, Cornblath DR, Griffin JW, McArthur JC. Epidermal innervation: changes with aging, topographic location, and in sensory neuropathy. J Neurol Sci 1999; 164 (02) 172-178
    CrossrefPubMedGoogle Scholar
  • 25 McArthur JC, Stocks EA, Hauer P, Cornblath DR, Griffin JW. Epidermal nerve fiber density: normative reference range and diagnostic efficiency. Arch Neurol 1998; 55 (12) 1513-1520
    CrossrefPubMedGoogle Scholar
  • 26 Vlcková-Moravcová E, Bednarík J, Dusek L, Toyka KV, Sommer C. Diagnostic validity of epidermal nerve fiber densities in painful sensory neuropathies. Muscle Nerve 2008; 37 (01) 50-60
    CrossrefPubMedGoogle Scholar
  • 27 Herrmann DN, Griffin JW, Hauer P, Cornblath DR, McArthur JC. Epidermal nerve fiber density and sural nerve morphometry in peripheral neuropathies. Neurology 1999; 53 (08) 1634-1640
    CrossrefPubMedGoogle Scholar
  • 28 Holland NR, Crawford TO, Hauer P, Cornblath DR, Griffin JW, McArthur JC. Small-fiber sensory neuropathies: clinical course and neuropathology of idiopathic cases. Ann Neurol 1998; 44 (01) 47-59
    CrossrefPubMedGoogle Scholar
  • 29 Lauria G, Morbin M, Lombardi R. , et al. Axonal swellings predict the degeneration of epidermal nerve fibers in painful neuropathies. Neurology 2003; 61 (05) 631-636
    CrossrefPubMedGoogle Scholar
  • 30 Periquet MI, Novak V, Collins MP. , et al. Painful sensory neuropathy: prospective evaluation using skin biopsy. Neurology 1999; 53 (08) 1641-1647
    CrossrefPubMedGoogle Scholar
  • 31 Lauria G, Sghirlanzoni A, Lombardi R, Pareyson D. Epidermal nerve fiber density in sensory ganglionopathies: clinical and neurophysiologic correlations. Muscle Nerve 2001; 24 (08) 1034-1039
    CrossrefPubMedGoogle Scholar
  • 32 Provitera V, Gibbons CH, Wendelschafer-Crabb G. , et al. The role of skin biopsy in differentiating small-fiber neuropathy from ganglionopathy. Eur J Neurol 2018; 25 (06) 848-853
    CrossrefPubMedGoogle Scholar
  • 33 Chémali KR, Zhou L. Small fiber degeneration in post-stroke complex regional pain syndrome I. Neurology 2007; 69 (03) 316-317
    CrossrefPubMedGoogle Scholar
  • 34 Wongmek A, Shin S, Zhou L. Skin biopsy in assessing meralgia paresthetica. Muscle Nerve 2016; 53 (04) 641-643
    CrossrefPubMedGoogle Scholar
  • 35 Lauria G, McArthur JC, Hauer PE, Griffin JW, Cornblath DR. Neuropathological alterations in diabetic truncal neuropathy: evaluation by skin biopsy. J Neurol Neurosurg Psychiatry 1998; 65 (05) 762-766
    CrossrefPubMedGoogle Scholar
  • 36 Oaklander AL, Rissmiller JG, Gelman LB, Zheng L, Chang Y, Gott R. Evidence of focal small-fiber axonal degeneration in complex regional pain syndrome-I (reflex sympathetic dystrophy). Pain 2006; 120 (03) 235-243
    CrossrefPubMedGoogle Scholar
  • 37 Lauria G, Bakkers M, Schmitz C. , et al. Intraepidermal nerve fiber density at the distal leg: a worldwide normative reference study. J Peripher Nerv Syst 2010; 15 (03) 202-207
    CrossrefPubMedGoogle Scholar
  • 38 Provitera V, Gibbons CH, Wendelschafer-Crabb G. , et al. A multi-center, multinational age- and gender-adjusted normative dataset for immunofluorescent intraepidermal nerve fiber density at the distal leg. Eur J Neurol 2016; 23 (02) 333-338
    CrossrefPubMedGoogle Scholar
  • 39 Jin P, Cheng L, Chen M, Zhou L. Low sensitivity of skin biopsy in diagnosing small fiber neuropathy in Chinese Americans. J Clin Neuromuscul Dis 2018; 20 (01) 1-6
    CrossrefPubMedGoogle Scholar
  • 40 Gibbons CH, Griffin JW, Polydefkis M. , et al. The utility of skin biopsy for prediction of progression in suspected small fiber neuropathy. Neurology 2006; 66 (02) 256-258
    CrossrefPubMedGoogle Scholar
  • 41 Herrmann DN, McDermott MP, Henderson D, Chen L, Akowuah K, Schifitto G. ; North East AIDS Dementia (NEAD) Consortium. Epidermal nerve fiber density, axonal swellings and QST as predictors of HIV distal sensory neuropathy. Muscle Nerve 2004; 29 (03) 420-427
    CrossrefPubMedGoogle Scholar
  • 42 Scott LJ, Griffin JW, Luciano C. , et al. Quantitative analysis of epidermal innervation in Fabry disease. Neurology 1999; 52 (06) 1249-1254
    CrossrefPubMedGoogle Scholar
  • 43 Smith AG, Ramachandran P, Tripp S, Singleton JR. Epidermal nerve innervation in impaired glucose tolerance and diabetes-associated neuropathy. Neurology 2001; 57 (09) 1701-1704
    CrossrefPubMedGoogle Scholar
  • 44 Dabby R, Vaknine H, Gilad R, Djaldetti R, Sadeh M. Evaluation of cutaneous autonomic innervation in idiopathic sensory small-fiber neuropathy. J Peripher Nerv Syst 2007; 12 (02) 98-101
    PubMedGoogle Scholar
  • 45 Nolano M, Provitera V, Caporaso G, Stancanelli A, Vitale DF, Santoro L. Quantification of pilomotor nerves: a new tool to evaluate autonomic involvement in diabetes. Neurology 2010; 75 (12) 1089-1097
    CrossrefPubMedGoogle Scholar
  • 46 Provitera V, Nolano M, Caporaso G. , et al. Postganglionic sudomotor denervation in patients with multiple system atrophy. Neurology 2014; 82 (24) 2223-2229
    CrossrefPubMedGoogle Scholar
  • 47 Nolano M, Provitera V, Donadio V. , et al. Cutaneous sensory and autonomic denervation in CADASIL. Neurology 2016; 86 (11) 1039-1044
    CrossrefPubMedGoogle Scholar
  • 48 Donadio V, Nolano M, Provitera V. , et al. Skin sympathetic adrenergic innervation: an immunofluorescence confocal study. Ann Neurol 2006; 59 (02) 376-381
    CrossrefPubMedGoogle Scholar
  • 49 Gibbons CH, Illigens BM, Wang N, Freeman R. Quantification of sweat gland innervation: a clinical-pathologic correlation. Neurology 2009; 72 (17) 1479-1486
    CrossrefPubMedGoogle Scholar
  • 50 Gibbons CH, Illigens BM, Wang N, Freeman R. Quantification of sudomotor innervation: a comparison of three methods. Muscle Nerve 2010; 42 (01) 112-119
    CrossrefPubMedGoogle Scholar
  • 51 Backonja MM, Attal N, Baron R. , et al. Value of quantitative sensory testing in neurological and pain disorders: NeuPSIG consensus. Pain 2013; 154 (09) 1807-1819
    CrossrefPubMedGoogle Scholar
  • 52 Shy ME, Frohman EM, So YT. , et al; Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Quantitative sensory testing: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 2003; 60 (06) 898-904
    CrossrefPubMedGoogle Scholar
  • 53 Low VA, Sandroni P, Fealey RD, Low PA. Detection of small-fiber neuropathy by sudomotor testing. Muscle Nerve 2006; 34 (01) 57-61
    CrossrefPubMedGoogle Scholar
  • 54 Sumner CJ, Sheth S, Griffin JW, Cornblath DR, Polydefkis M. The spectrum of neuropathy in diabetes and impaired glucose tolerance. Neurology 2003; 60 (01) 108-111
    CrossrefPubMedGoogle Scholar
  • 55 Zhou L, Li J, Ontaneda D, Sperling J. Metabolic syndrome in small fiber sensory neuropathy. J Clin Neuromuscul Dis 2011; 12 (04) 235-243
    CrossrefPubMedGoogle Scholar
  • 56 Smith AG, Rose K, Singleton JR. Idiopathic neuropathy patients are at high risk for metabolic syndrome. J Neurol Sci 2008; 273 (1–2): 25-28
    CrossrefPubMedGoogle Scholar
  • 57 Tesfaye S, Chaturvedi N, Eaton SE. , et al; EURODIAB Prospective Complications Study Group. Vascular risk factors and diabetic neuropathy. N Engl J Med 2005; 352 (04) 341-350
    CrossrefPubMedGoogle Scholar
  • 58 Koike H, Mori K, Misu K. , et al. Painful alcoholic polyneuropathy with predominant small-fiber loss and normal thiamine status. Neurology 2001; 56 (12) 1727-1732
    CrossrefPubMedGoogle Scholar
  • 59 Mellion ML, Silbermann E, Gilchrist JM, Machan JT, Leggio L, de la Monte S. Small-fiber degeneration in alcohol-related peripheral neuropathy. Alcohol Clin Exp Res 2014; 38 (07) 1965-1972
    CrossrefPubMedGoogle Scholar
  • 60 Kuo HC, Huang CC, Tsai YT, Chu CC, Hsieh ST, Chu NS. Acute painful neuropathy in thallium poisoning. Neurology 2005; 65 (02) 302-304
    CrossrefPubMedGoogle Scholar
  • 61 Chao CC, Sun HY, Chang YC, Hsieh ST. Painful neuropathy with skin denervation after prolonged use of linezolid. J Neurol Neurosurg Psychiatry 2008; 79 (01) 97-99
    CrossrefPubMedGoogle Scholar
  • 62 Heckmann JG, Dütsch M, Schwab S. Linezolid-associated small-fiber neuropathy. J Peripher Nerv Syst 2008; 13 (02) 157-158
    CrossrefPubMedGoogle Scholar
  • 63 Hobson-Webb LD, Roach ES, Donofrio PD. Metronidazole: newly recognized cause of autonomic neuropathy. J Child Neurol 2006; 21 (05) 429-431
    CrossrefPubMedGoogle Scholar
  • 64 Tan IL, Polydefkis MJ, Ebenezer GJ, Hauer P, McArthur JC. Peripheral nerve toxic effects of nitrofurantoin. Arch Neurol 2012; 69 (02) 265-268
    CrossrefPubMedGoogle Scholar
  • 65 Zivkovic SA, Lacomis D, Giuliani MJ. Sensory neuropathy associated with metronidazole: report of four cases and review of the literature. J Clin Neuromuscul Dis 2001; 3 (01) 8-12
    CrossrefPubMedGoogle Scholar
  • 66 Etminan M, Brophy JM, Samii A. Oral fluoroquinolone use and risk of peripheral neuropathy: a pharmacoepidemiologic study. Neurology 2014; 83 (14) 1261-1263
    CrossrefPubMedGoogle Scholar
  • 67 Giannoccaro MP, Donadio V, Gomis Pèrez C, Borsini W, Di Stasi V, Liguori R. Somatic and autonomic small fiber neuropathy induced by bortezomib therapy: an immunofluorescence study. Neurol Sci 2011; 32 (02) 361-363
    CrossrefPubMedGoogle Scholar
  • 68 Birnbaum J, Bingham III CO. Non-length-dependent and length-dependent small-fiber neuropathies associated with tumor necrosis factor (TNF)-inhibitor therapy in patients with rheumatoid arthritis: expanding the spectrum of neurological disease associated with TNF-inhibitors. Semin Arthritis Rheum 2014; 43 (05) 638-647
    CrossrefPubMedGoogle Scholar
  • 69 Gibbons CH, Freeman R. Treatment-induced diabetic neuropathy: a reversible painful autonomic neuropathy. Ann Neurol 2010; 67 (04) 534-541
    CrossrefPubMedGoogle Scholar
  • 70 Gibbons CH, Freeman R. Treatment-induced neuropathy of diabetes: an acute, iatrogenic complication of diabetes. Brain 2015; 138 (Pt 1): 43-52
    CrossrefPubMedGoogle Scholar
  • 71 Hoeijmakers JG, Faber CG, Merkies IS, Waxman SG. Painful peripheral neuropathy and sodium channel mutations. Neurosci Lett 2015; 596: 51-59
    CrossrefPubMedGoogle Scholar
  • 72 Dib-Hajj SD, Tyrrell L, Black JA, Waxman SG. NaN, a novel voltage-gated Na channel, is expressed preferentially in peripheral sensory neurons and down-regulated after axotomy. Proc Natl Acad Sci U S A 1998; 95 (15) 8963-8968
    CrossrefPubMedGoogle Scholar
  • 73 Persson AK, Black JA, Gasser A, Cheng X, Fischer TZ, Waxman SG. Sodium-calcium exchanger and multiple sodium channel isoforms in intra-epidermal nerve terminals. Mol Pain 2010; 6: 84
    PubMedGoogle Scholar
  • 74 Zhao P, Barr TP, Hou Q. , et al. Voltage-gated sodium channel expression in rat and human epidermal keratinocytes: evidence for a role in pain. Pain 2008; 139 (01) 90-105
    CrossrefPubMedGoogle Scholar
  • 75 Fang X, Djouhri L, Black JA, Dib-Hajj SD, Waxman SG, Lawson SN. The presence and role of the tetrodotoxin-resistant sodium channel Na(v)1.9 (NaN) in nociceptive primary afferent neurons. J Neurosci 2002; 22 (17) 7425-7433
    CrossrefPubMedGoogle Scholar
  • 76 Faber CG, Hoeijmakers JG, Ahn HS. , et al. Gain of function Naν1.7 mutations in idiopathic small fiber neuropathy. Ann Neurol 2012; 71 (01) 26-39
    CrossrefPubMedGoogle Scholar
  • 77 Faber CG, Lauria G, Merkies IS. , et al. Gain-of-function Nav1.8 mutations in painful neuropathy. Proc Natl Acad Sci U S A 2012; 109 (47) 19444-19449
    CrossrefPubMedGoogle Scholar
  • 78 Huang J, Han C, Estacion M. , et al; PROPANE Study Group. Gain-of-function mutations in sodium channel Na(v)1.9 in painful neuropathy. Brain 2014; 137 (Pt 6): 1627-1642
    CrossrefPubMedGoogle Scholar
  • 79 Adams D, Suhr OB, Hund E. , et al; European Network for TTR-FAP (ATTReuNET). First European consensus for diagnosis, management, and treatment of transthyretin familial amyloid polyneuropathy. Curr Opin Neurol 2016; 29 (Suppl. 01) S14-S26
    CrossrefPubMedGoogle Scholar
  • 80 de Greef BT, Hoeijmakers JG, Wolters EE. , et al. No Fabry disease in patients presenting with isolated small fiber neuropathy. PLoS One 2016; 11 (02) e0148316
    CrossrefPubMedGoogle Scholar
  • 81 Tavee JO. Office approach to small fiber neuropathy. Cleve Clin J Med 2018; 85 (10) 801-812
    CrossrefPubMedGoogle Scholar
  • 82 Smith AG, Russell J, Feldman EL. , et al. Lifestyle intervention for pre-diabetic neuropathy. Diabetes Care 2006; 29 (06) 1294-1299
    CrossrefPubMedGoogle Scholar
  • 83 Look ARG. ; Look AHEAD Research Group. Effects of a long-term lifestyle modification programme on peripheral neuropathy in overweight or obese adults with type 2 diabetes: the Look AHEAD study. Diabetologia 2017; 60 (06) 980-988
    CrossrefPubMedGoogle Scholar
  • 84 Brannagan III TH, Hays AP, Chin SS. , et al. Small-fiber neuropathy/neuronopathy associated with celiac disease: skin biopsy findings. Arch Neurol 2005; 62 (10) 1574-1578
    PubMedGoogle Scholar
  • 85 Hoitsma E, Faber CG, van Santen-Hoeufft M, De Vries J, Reulen JP, Drent M. Improvement of small fiber neuropathy in a sarcoidosis patient after treatment with infliximab. Sarcoidosis Vasc Diffuse Lung Dis 2006; 23 (01) 73-77
    PubMedGoogle Scholar
  • 86 Acevedo JC, Amaya A, Casasola OdeL. , et al. Guidelines for the diagnosis and management of neuropathic pain: consensus of a group of Latin American experts. J Pain Palliat Care Pharmacother 2009; 23 (03) 261-281
    CrossrefPubMedGoogle Scholar
  • 87 Bohlega S, Alsaadi T, Amir A. , et al. Guidelines for the pharmacological treatment of peripheral neuropathic pain: expert panel recommendations for the middle East region. J Int Med Res 2010; 38 (02) 295-317
    PubMedGoogle Scholar
  • 88 Bril V, England J, Franklin GM. , et al; American Academy of Neurology; American Association of Neuromuscular and Electrodiagnostic Medicine; American Academy of Physical Medicine and Rehabilitation. Evidence-based guideline: treatment of painful diabetic neuropathy: report of the American Academy of Neurology, the American Association of Neuromuscular and Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation. Neurology 2011; 76 (20) 1758-1765
    CrossrefPubMedGoogle Scholar
  • 89 Dworkin RH, O'Connor AB, Audette J. , et al. Recommendations for the pharmacological management of neuropathic pain: an overview and literature update. Mayo Clin Proc 2010; 85 (3, Suppl): S3-S14
    PubMedGoogle Scholar
  • 90 Hovaguimian A, Gibbons CH. Diagnosis and treatment of pain in small-fiber neuropathy. Curr Pain Headache Rep 2011; 15 (03) 193-200
    CrossrefPubMedGoogle Scholar
  • 91 Moulin D, Boulanger A, Clark AJ. , et al; Canadian Pain Society. Pharmacological management of chronic neuropathic pain: revised consensus statement from the Canadian Pain Society. Pain Res Manag 2014; 19 (06) 328-335
    PubMedGoogle Scholar
  • 92 Gilron I, Bailey JM, Tu D, Holden RR, Jackson AC, Houlden RL. Nortriptyline and gabapentin, alone and in combination for neuropathic pain: a double-blind, randomised controlled crossover trial. Lancet 2009; 374 (9697): 1252-1261
    CrossrefPubMedGoogle Scholar
  • 93 Hoffman EM, Watson JC, St Sauver J, Staff NP, Klein CJ. Association of long-term opioid therapy with functional status, adverse outcomes, and mortality among patients with polyneuropathy. JAMA Neurol 2017; 74 (07) 773-779
    CrossrefPubMedGoogle Scholar
  • 94 Khoshnoodi MA, Truelove S, Burakgazi A, Hoke A, Mammen AL, Polydefkis M. Longitudinal assessment of small fiber neuropathy: evidence of a non-length-dependent distal axonopathy. JAMA Neurol 2016; 73 (06) 684-690
    CrossrefPubMedGoogle Scholar